Podcast Summary: The Thyroid Fixer – Episode 596
Title: Does Hormone Replacement Cause Cancer? 3 Top Doctors Weigh In
Host: Dr. Amie Hornaman
Guests: Dr. Lindsey Berkson, Dr. Julie Taguchi, Dr. Jen Simmons
Date: January 16, 2026
Episode Overview
This powerful episode tackles one of the most persistent fears in women's health: Does hormone replacement therapy (HRT) cause cancer? Host Dr. Amie Hornaman brings together three leading experts—Dr. Lindsey Berkson, Dr. Julie Taguchi, and Dr. Jen Simmons—to break down the origins of this fear, the nuances of the research (especially the infamous Women’s Health Initiative study), the difference between synthetic and bioidentical hormones, and what the real science says about the risks and benefits of HRT for women, including those with a history or risk of breast cancer. The overarching message: Hormones, when used appropriately, are not the enemy—in many cases, they are protective.
Key Discussion Points & Insights
1. Where Did the Fear Come From? (WHI Study)
-
The Women's Health Initiative (WHI), launched in the early ‘90s, studied the effects of specific hormone treatments: oral Premarin (from horses) and medroxyprogesterone acetate (a synthetic progestin), not human-identical (bioidentical) hormones.
-
In 2002, initial data showed a 26% increase in breast cancer in one arm (just one extra case out of thousands), sparking a wave of fear.
-
Quote:
- “Doctors heard that, they said, oh, 26%. Like one in four… But it was just a 20, 26% increase against the placebo, and the risk was 0.4% a year. It’s a tiny, tiny risk.” – Dr. Julie Taguchi [11:52]
-
The absolute risk was tiny, most cases had preexisting, undiagnosed cancers, and subsequent re-analyses have debunked the commonly-held misinterpretations.
2. Reanalysis & New Evidence
-
Subsequent studies and re-analyses of WHI data (see 19-year reanalysis and major Medicare studies) found that HRT—especially estrogen—reduces breast cancer risk and mortality:
- “If a woman was ever on estrogen… it decreased her incidence of getting breast cancer by 23%. If she got breast cancer with a history of being on hormones… it decreased risk of dying from this disease by 44%.” – Dr. Lindsey Berkson [52:39]
- Recent data shows HRT lowers risks of breast, ovarian, uterine, and colorectal cancers, and substantially reduces risk for Alzheimer’s and cardiovascular disease.
-
The confusion persists mainly because negative results made headlines, while positive follow-up studies did not.
- “Did this make headline news like the bad news did in 2002? No. No, no, no.” – Dr. Lindsey Berkson [53:16]
3. Benefits of Hormone Replacement
- Bone health: Progesterone and rhythmic hormone dosing can reverse osteoporosis & osteopenia. [07:36]
- “You can turn it around like nobody’s business. It’s really interesting.” – Dr. Julie Taguchi
- Muscle & Metabolism: Testosterone is crucial for women’s muscle mass, insulin sensitivity, and mood. [08:17–09:53]
- Cognition & Longevity: Multiple studies show decreased incidence of dementia and longer, healthier lives for HRT users. [54:08–54:36]
- Protection against cancers: Noted for both men (testosterone and prostate cancer) and women (estrogen and breast/gynecologic cancers).
4. Bioidentical vs. Synthetic Hormones
- Bioidentical (BHRT): Molecules identical to the body’s own; shown to be safe and protective.
- Synthetic/non-bioidentical: Premarin, synthetic progestins, and old-style birth control pills; associated with more side effects and risks.
- Quote:
- “The distinction that I want to make is not so much synthetic vs. non-synthetic… but bioidentical vs. non-bioidentical.” – Dr. Jen Simmons [35:17]
- “We only have data that shows [bioidenticals] are safe and effective.” – Dr. Jen Simmons [37:26]
- Quote:
5. Cancer Mechanisms & Recurrence
-
Having estrogen/progesterone receptors on breast cells is normal; their positivity in cancer is not a reason to avoid HRT.
- “Normal breast tissue has estrogen and progesterone receptors... Oncology, estrogen and progesterone receptor positivity is a good thing.” – Dr. Julie Taguchi [17:04]
-
Fifty percent of tumors may be driven by estrogen, the other half by unrelated factors (insulin, genetics, lifestyle).
-
Recurrence is multifactorial—not solely hormone-driven.
- “It’s not just taking hormones or avoiding hormones that’s going to determine our ultimate outcome.” – Dr. Amie Hornaman [22:47]
6. Lifestyle and Other Risk Factors
- Behaviors like smoking, alcohol use, obesity, and metabolic dysfunction are much bigger cancer risk factors than HRT [22:47–23:50]
- “When I see somebody for the first time for breast cancer, I can find multiple risk factors in every patient.” – Dr. Julie Taguchi [23:50]
- The modern cancer epidemic is more related to environment, metabolic health, and inflammation than hormones.
7. Real-Life Clinical Experience & Quality of Life
- Women who take HRT after breast cancer, including survivors with HR+ disease, often have better quality and longer life.
- “If they take hormone replacement after they have breast cancer, they have greater longevity and greater quality of life.” – Dr. Jen Simmons [47:56]
- HRT relieves symptoms (hot flashes, insomnia, muscle/bone loss, brain fog, vaginal atrophy) which severely impact day-to-day life.
- “We are not meant to be without estrogen. We have estrogen receptors everywhere for a reason...our brains can’t work without it, our heart can’t work without it...” – Dr. Jen Simmons [45:26]
Notable Quotes & Moments (with timestamps)
-
On the damage of the WHI study and bad statistics:
- “It was a major disservice to women. The doctors didn’t understand the statistics...It really was a disservice.” – Dr. Julie Taguchi [12:40]
-
On why the fear persists:
- “Medicine is like trying to move the Titanic away from the icebergs...the way things have always been done, the way their association says to do it...so they’re not interested in stepping outside the standard of care, because otherwise they’ll be at risk of being sued.” – Dr. Lindsey Berkson [60:32]
-
On the protective value of starting HRT:
- “They looked at 7 million Medicare people...if women had been on hormone replacement for five years, they had a 33%...decreased incidence of breast cancer. And not just less breast cancer, less ovarian cancer, uterine cancer, and less colorectal cancer.” – Dr. Lindsey Berkson [54:38]
-
On estrogen's centrality to women's health:
- “Estrogen is not the problem. And I cannot say that enough times. Estrogen is not the problem.” – Dr. Jen Simmons [32:13]
- “Why would Mother Nature make the very hormones that drive humanity...cancer-causing?” – Dr. Lindsey Berkson [58:36]
-
On patients’ quality of life and evidence-based decision-making:
- “...the biggest risk for breast cancer—if you have boobs in the first place, and you have birthdays. Boobs and birthdays—the older you get, the more risk you have for cancer.” – Dr. Julie Taguchi [24:23]
Memorable Story
- Dr. Hornaman recounts (with Dr. Jen Simmons and Dr. Berkson's support) a striking case of a man with advanced cancer given testosterone (against the usual advice):
- “His cancer shrunk, and he ended up living way beyond—he was given six months, he’s now like six years down the road, cancer free.” [49:02]
Practical Guidance for Listeners
Key Takeaways for Women Considering HRT:
- HRT does NOT inherently cause cancer. Modern evidence is robust in showing safety, particularly with bioidentical hormones.
- Benefits include: Bone, muscle, brain, sexual, mood, metabolic, and even cancer prevention, when started in the right clinical context.
- Women with a history of breast cancer (even ER+/PR+): Decisions must be individualized, but informed consent and risk/benefit discussion often favor HRT, especially for quality of life.
- Start Earlier: Optimal benefits seen when HRT is started within 10 years of menopause, but age alone shouldn’t be a contraindication.
- It's about context and partnership: Personalized care, thorough assessment of all risk factors, and patient education are key.
- Lifestyle support is crucial: HRT is not a magic bullet without addressing sleep, diet, exercise, metabolic and inflammatory health.
Important Segment Timestamps
| Topic | Speakers | Timestamp | |-------|----------|-----------| | Progesterone/Bone Health | Dr. Taguchi | 07:36 | | Testosterone's Role in Women | Dr. Taguchi & Host | 08:01–09:53 | | WHI Study Breakdown & Myths | Dr. Taguchi | 10:58–14:47 | | Bioidentical vs. Synthetic Hormones | Dr. Jen Simmons | 35:17–37:00 | | HRT and Quality of Life After Cancer | Dr. Jen Simmons | 44:50–47:56 | | Data Showing HRT Reduces Cancer Risk | Dr. Berkson | 52:39–54:38 | | Why Doctors Still Resist HRT | Dr. Berkson | 59:52–61:49 | | Recurrence Factors Beyond Hormones | Multiple | 17:04–23:50 |
Conclusion
This episode powerfully dismantles the myths behind hormone therapy and cancer risk, replacing fear with facts. The overwhelming message: Hormones are essential for healthspan, and the risk of cancer with properly prescribed HRT is vastly overstated—even in women with breast cancer histories—while the risks of NOT using them are underappreciated. As Dr. Berkson says, “If you want to age better, hormones must be a part of that foundational tool bag that you develop.” [01:17]
Listeners are encouraged to challenge outdated medical advice, seek truly personalized care, and recognize that the real danger is suffering from unnecessary symptoms due to hormone deficiency and misinformation.
